Synergistic	O
interactions	O
between	O
overlapping	B-DNA
binding	I-DNA
sites	I-DNA
for	O
the	O
serum	B-protein
response	I-protein
factor	I-protein
and	O
ELK-1	B-protein
proteins	I-protein
mediate	O
both	O
basal	O
enhancement	O
and	O
phorbol	O
ester	O
responsiveness	O
of	O
primate	B-DNA
cytomegalovirus	I-DNA
major	I-DNA
immediate-early	I-DNA
promoters	I-DNA
in	O
monocyte	O
and	O
T-lymphocyte	B-cell_type
cell	O
types	O
.	O

Cytomegalovirus	O
(	O
CMV	O
)	O
infection	O
is	O
nonpermissive	O
or	O
persistent	O
in	O
many	O
lymphoid	B-cell_type
and	I-cell_type
myeloid	I-cell_type
cell	I-cell_type
types	I-cell_type
but	O
can	O
be	O
activated	O
in	O
differentiated	B-cell_type
macrophages	I-cell_type
.	O

We	O
have	O
shown	O
elsewhere	O
that	O
both	O
the	O
major	B-DNA
immediate-early	I-DNA
gene	I-DNA
(	O
MIE	B-DNA
)	O
and	O
lytic	O
cycle	O
infectious	O
progeny	O
virus	O
expression	O
can	O
be	O
induced	O
in	O
otherwise	O
nonpermissive	O
monocyte-like	B-cell_line
U-937	I-cell_line
cell	I-cell_line
cultures	I-cell_line
infected	O
with	O
either	O
human	O
CMV	O
(	O
HCMV	O
)	O
or	O
simian	O
CMV	O
(	O
SCMV	O
)	O
by	O
treatment	O
with	O
the	O
phorbol	O
ester	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
.	O

Two	O
multicopy	B-DNA
basal	I-DNA
enhancer	I-DNA
motifs	I-DNA
within	O
the	O
SCMV	O
MIE	B-DNA
enhancer	I-DNA
,	O
namely	O
,	O
11	O
copies	O
of	O
the	O
16-bp	O
cyclic	B-DNA
AMP	I-DNA
response	I-DNA
element	I-DNA
(	O
CRE	B-DNA
)	O
and	O
3	O
copies	O
of	O
novel	O
17-bp	O
serum	B-DNA
response	I-DNA
factor	I-DNA
(	I-DNA
SRF	I-DNA
)	I-DNA
binding	I-DNA
sites	I-DNA
referred	O
to	O
as	O
the	O
SNE	B-DNA
(	O
SRF/NFkappaB-like	B-DNA
element	I-DNA
)	O
,	O
as	O
well	O
as	O
four	O
classical	O
NFkappaB	B-DNA
sites	I-DNA
within	O
the	O
HCMV	O
version	O
,	O
contribute	O
to	O
TPA	O
responsiveness	O
in	O
transient	O
assays	O
in	O
monocyte	B-cell_type
and	I-cell_type
T-cell	I-cell_type
types	I-cell_type
.	O

The	O
SCMV	B-DNA
SNE	I-DNA
sites	I-DNA
contain	O
potential	O
overlapping	O
core	O
recognition	O
binding	O
motifs	O
for	O
SRF	B-protein
,	O
Rel/NFkappaB	B-protein
,	O
ETS	B-protein
,	O
and	O
YY1	B-protein
class	I-protein
transcription	I-protein
factors	I-protein
but	O
fail	O
to	O
respond	O
to	O
either	O
serum	B-protein
or	I-protein
tumor	I-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
.	O

Therefore	O
,	O
to	O
evaluate	O
the	O
mechanism	O
of	O
TPA	O
responsiveness	O
of	O
the	O
SNE	B-DNA
motifs	I-DNA
and	O
of	O
a	O
related	O
16-bp	O
SEE	B-DNA
(	O
SRF/ETS	B-DNA
element	I-DNA
)	O
motif	O
found	O
in	O
the	O
HCMV	B-DNA
and	I-DNA
chimpanzee	I-DNA
CMV	I-DNA
MIE	I-DNA
enhancers	I-DNA
,	O
we	O
have	O
examined	O
the	O
functional	O
responses	O
and	O
protein	O
binding	O
properties	O
of	O
multimerized	B-DNA
wild-type	I-DNA
and	I-DNA
mutant	I-DNA
elements	I-DNA
added	O
upstream	O
to	O
the	O
SCMV	B-DNA
MIE	I-DNA
or	O
simian	B-DNA
virus	I-DNA
40	I-DNA
minimal	I-DNA
promoter	I-DNA
regions	I-DNA
in	O
the	O
U-937	B-cell_line
,	O
K-562	B-cell_line
,	O
HL-60	B-cell_line
,	O
THP-1	B-cell_line
,	O
and	O
Jurkat	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Unlike	O
classical	O
NFkappaB	B-DNA
sites	I-DNA
,	O
neither	O
the	O
SNE	B-DNA
nor	O
the	O
SEE	B-DNA
motif	I-DNA
responded	O
to	O
phosphatase	O
inhibition	O
by	O
okadaic	O
acid	O
.	O

However	O
,	O
the	O
TPA	O
responsiveness	O
of	O
both	O
CMV	B-DNA
elements	I-DNA
proved	O
to	O
involve	O
synergistic	O
interactions	O
between	O
the	O
core	O
SRF	B-DNA
binding	I-DNA
site	I-DNA
(	O
CCATATATGG	O
)	O
and	O
the	O
adjacent	O
inverted	O
ETS	B-DNA
binding	I-DNA
motifs	I-DNA
(	O
TTCC	O
)	O
,	O
which	O
correlated	O
directly	O
with	O
formation	O
of	O
a	O
bound	O
tripartite	B-protein
complex	I-protein
containing	O
both	O
the	O
cellular	O
SRF	B-protein
and	O
ELK-1	B-protein
proteins	I-protein
.	O

This	O
protein	B-protein
complex	I-protein
was	O
more	O
abundant	O
in	O
U-937	O
,	O
K-562	O
,	O
and	O
HeLa	O
cell	O
extracts	O
than	O
in	O
Raji	B-cell_line
,	O
HF	B-cell_line
,	O
BALB/c	B-cell_line
3T3	I-cell_line
,	O
or	O
HL-60	B-cell_line
cells	I-cell_line
,	O
but	O
the	O
binding	O
activity	O
was	O
altered	O
only	O
twofold	O
after	O
TPA	O
treatment	O
.	O

A	O
40-fold	O
stimulation	O
of	O
chloramphenicol	B-protein
acetyltransferase	I-protein
activity	O
mediated	O
by	O
four	O
tandem	B-DNA
repeats	I-DNA
of	O
the	O
SNE	B-DNA
could	O
be	O
induced	O
within	O
2	O
h	O
(	O
and	O
up	O
to	O
250-fold	O
within	O
6	O
h	O
)	O
after	O
addition	O
of	O
TPA	O
in	O
DNA-transfected	B-cell_line
U-937	I-cell_line
cells	I-cell_line
,	O
indicating	O
that	O
the	O
stimulation	O
appeared	O
likely	O
to	O
be	O
a	O
true	O
protein	B-protein
kinase	I-protein
C	I-protein
-mediated	O
signal	O
transduction	O
event	O
rather	O
than	O
a	O
differentiation	O
response	O
.	O

Slight	O
differences	O
in	O
the	O
sequence	O
of	O
the	O
core	B-DNA
SRF	I-DNA
binding	I-DNA
site	I-DNA
compared	O
with	O
that	O
of	O
the	O
classical	O
c-Fos	B-DNA
promoter	I-DNA
serum	I-DNA
response	I-DNA
element	I-DNA
,	O
together	O
with	O
differences	O
in	O
the	O
spacing	O
between	O
the	O
SRF	B-DNA
and	I-DNA
ETS	I-DNA
motifs	I-DNA
,	O
appear	O
to	O
account	O
for	O
the	O
inability	O
of	O
the	O
SCMV	B-DNA
SNEs	I-DNA
to	O
respond	O
to	O
serum	O
induction	O
.	O

